Delayed-Release Oral Mesalamine 4.8 g/day (800 mg tablets) Compared with 2.4 g/day (400 mg tablets) for the Treatment of Mildly to Moderately Active Ulcerative Colitis: The ASCEND...

by Stephen B Hanauer, William J Sandborn, Christian Dallaire, André Archambault, Bruce Yacyshyn, Chyon Yeh, Nancy Smith-Hall
Published 2007-01-01

Aqueous MEA and Ammonia Sorption-Induced Damage in Keratin Fibers

by Naima Ali, Jennifer Marsh, Simon Godfrey, Daryl R. Williams
Published 2018-10-01

The Wild Bird Center Experience: Using Business as a Conduit for Environmental Consciousness

by Lewis, Nicole Lee
Published 2009

Federal Failures: The Ohio-Michigan Boundary Dispute

by Badenhop, Stephen W.
Published 2008

Pemphigoid gestationis and intravenous immunoglobulin therapy

by Anes Yang, MD, BMed, MPH, Elizabeth Uhlenhake, MD, FAAD, Dedee F. Murrell, MA, BMBCh, FAAD, MD, FACD, FRCP
Published 2018-09-01

Haunted Places in US Culture

by Bojan Žikić
Published 2020-07-01

Inspired by vitamin A for anti‐ageing: Searching for plant‐derived functional retinoid analogues

by N. J. Sadgrove, J. E. Oblong, M. S. J. Simmonds
Published 2021-09-01

An Innovative Disease‐Drug‐Trial Framework to Guide Binge Eating Disorder Drug Development: A Case Study for Topiramate

by Shamir N. Kalaria, Susan L. McElroy, Jogarao Gobburu, Mathangi Gopalakrishnan
Published 2020-01-01